NM_001040151.2:c.29T>C
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_001040151.2(SCN3B):c.29T>C(p.Leu10Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000425 in 1,614,104 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001040151.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SCN3B | NM_001040151.2 | c.29T>C | p.Leu10Pro | missense_variant | Exon 2 of 7 | ENST00000299333.8 | NP_001035241.1 | |
SCN3B | NM_018400.4 | c.29T>C | p.Leu10Pro | missense_variant | Exon 1 of 6 | NP_060870.1 | ||
SCN3B | XM_011542897.3 | c.29T>C | p.Leu10Pro | missense_variant | Exon 2 of 7 | XP_011541199.1 | ||
LOC105369543 | XR_948124.4 | n.89A>G | non_coding_transcript_exon_variant | Exon 1 of 3 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000335 AC: 51AN: 152210Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000203 AC: 51AN: 251474Hom.: 0 AF XY: 0.000243 AC XY: 33AN XY: 135910
GnomAD4 exome AF: 0.000434 AC: 635AN: 1461894Hom.: 0 Cov.: 31 AF XY: 0.000392 AC XY: 285AN XY: 727248
GnomAD4 genome AF: 0.000335 AC: 51AN: 152210Hom.: 0 Cov.: 33 AF XY: 0.000255 AC XY: 19AN XY: 74372
ClinVar
Submissions by phenotype
Brugada syndrome 7 Pathogenic:2Uncertain:1Other:1
- -
- -
- -
This sequence change replaces leucine, which is neutral and non-polar, with proline, which is neutral and non-polar, at codon 10 of the SCN3B protein (p.Leu10Pro). This variant is present in population databases (rs121918282, gnomAD 0.04%), and has an allele count higher than expected for a pathogenic variant. This missense change has been observed in individual(s) with clinical features of SCN3B-related conditions (PMID: 20031595, 21051419, 22284586, 25650408, 25757662, 29247119, 31043699). ClinVar contains an entry for this variant (Variation ID: 2470). An algorithm developed to predict the effect of missense changes on protein structure and function outputs the following: PolyPhen-2: "Benign". The proline amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. Experimental studies have shown that this missense change affects SCN3B function (PMID: 20031595, 21051419, 23257389). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
not provided Uncertain:2
Identified in patients with arrhythmia referred for genetic testing at GeneDx and reported in association with Brugada syndrome, atrial fibrillation, prolonged QT interval, and sudden unexplained infant death syndrome in published literature (PMID: 20031595, 21051419, 25650408, 25757662, 25691686, 23861362); In silico analysis indicates that this missense variant does not alter protein structure/function; Variants in candidate genes are classified as variants of uncertain significance in accordance with ACMG guidelines (PMID: 25741868); This variant is associated with the following publications: (PMID: 24667784, 22284586, 25757662, 23414114, 24055113, 24144883, 26728597, 25668026, 25650408, 21051419, 25691686, 20558140, 36362949, 34572065, 35083300, 31961030, 35385795, 35456365, LauK2016[Abstract], 32684122, 36354758, 34495297, 20031595, 23257389, 34867379, 30821013, 31019283, 31043699, 29247119, 38450374, 23861362) -
- -
Atrial fibrillation, familial, 16 Pathogenic:1
- -
not specified Uncertain:1
Variant classified as Uncertain Significance - Favor Benign. The p.Leu10Pro vari ant in SCN3B has been reported in 1 individual with Brugada syndrome and 1 indiv idual with atrial fibrillation (Hu 2009, Olesen 2011, Olesen 2014). In addition, this variant has been identified in 19/66726 of European chromosomes by the Exo me Aggregation Consortium (ExAC, http://exac.broadinstitute.org/; dbSNP 12191828 2). In vitro functional studies provide some evidence that this variant may impa ct protein function (Hu 2009, Olesen 201), though these types of assays may not accurately represent biological function. Leucine (Leu) at position 10 is not co nserved in mammals with 3 mammals (gibbon, hedgehog, and shrew) carrying a proli ne (Pro) at this position, raising the possibility that this change may be toler ated. In summary, although the clinical significance of the p.Leu10Pro variant is uncertain it is less likely disease causing. -
Brugada syndrome Uncertain:1
- -
Cardiovascular phenotype Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at